When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.
A novel method to manipulate the inner structure of cells connects several scientific fields and could represent a significant step in the treatment of neurodegenerative diseases, such as Alzheimer's ...